These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 39039447)

  • 1. Variant analysis and PGT-M of OTC gene in a Chinese family with ornithine carbamoyltransferase deficiency.
    Zhou Y; Jiang X; Zhang Y; Zhang Y; Sun F; Ma Y
    BMC Pregnancy Childbirth; 2024 Jul; 24(1):491. PubMed ID: 39039447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene Mutation Analysis and Prenatal Diagnosis of the Ornithine Transcarbamylase (OTC) Gene in Two Families with Ornithine Transcarbamylase Deficiency.
    Li S; Cai Y; Shi C; Liu M; Liu B; Lin L; Xiao X; Hao H
    Med Sci Monit; 2018 Oct; 24():7431-7437. PubMed ID: 30333473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Genetic testing and prenatal diagnosis in seven pedigrees affected with ornithine transcarbamylase deficiency].
    Liu N; Feng Y; Jiang M; Kong X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Feb; 37(2):106-109. PubMed ID: 32034732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Genetic analysis and prenatal diagnosis for a Chinese pedigree affected with co-morbid Ornithine carbamoyl transferase deficiency and MECP2 duplication syndrome].
    Zhang Q; Hao S; Hui L; Zheng L; Wang X; Feng X; Liu F; Chen X; Zhou B; Wang Y; Zhang C
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2024 Mar; 41(3):306-311. PubMed ID: 38448019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of clinical features, biochemical analysis and gene mutations in one Chinese pedigree with neonatal-onset ornithine transcarbamylase deficiency].
    Sun WH; Yang Y; Zhang YP; Li XT; Zhang M; Cao Y; Wang Y
    Zhonghua Er Ke Za Zhi; 2011 May; 49(5):356-60. PubMed ID: 21624287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of the liver enzyme ornithine carbamoyltransferase (OTC) in blood: LC-MS/MS assay for non-invasive diagnosis of ornithine carbamoyltransferase deficiency.
    Krijt J; Sokolová J; Ješina P; Dvořáková L; Řeboun M; Brennerová K; Mistrík M; Zeman J; Honzík T; Kožich V
    Clin Chem Lab Med; 2017 Jul; 55(8):1168-1177. PubMed ID: 28107167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and genetic analysis of five Chinese patients with urea cycle disorders.
    Zheng Z; Lin Y; Lin W; Zhu L; Jiang M; Wang W; Fu Q
    Mol Genet Genomic Med; 2020 Jul; 8(7):e1301. PubMed ID: 32410394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal treatment of ornithine transcarbamylase deficiency.
    Wilnai Y; Blumenfeld YJ; Cusmano K; Hintz SR; Alcorn D; Benitz WE; Berquist WE; Bernstein JA; Castillo RO; Concepcion W; Cowan TM; Cox KL; Lyell DJ; Esquivel CO; Homeyer M; Hudgins L; Hurwitz M; Palma JP; Schelley S; Akula VP; Summar ML; Enns GM
    Mol Genet Metab; 2018 Mar; 123(3):297-300. PubMed ID: 29396029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular diagnosis of OTC gene mutation in a Chinese family with ornithine transcarbamylase deficiency].
    Meng LL; Jiang T; Qin L; Ma DY; Chen YL; Han SP; Yu ZB; Guo XR; Hu P; Xu ZF
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Apr; 30(2):195-8. PubMed ID: 23568734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OTC gene in ornithine transcarbamylase deficiency: clinical course and mutational spectrum in seven Korean patients.
    Lee JH; Kim GH; Yoo HW; Cheon CK
    Pediatr Neurol; 2014 Sep; 51(3):354-359.e1. PubMed ID: 25011434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An exon 1 deletion in OTC identified using chromosomal microarray analysis in a mother and her two affected deceased newborns: implications for the prenatal diagnosis of ornithine transcarbamylase deficiency.
    Quintero-Rivera F; Deignan JL; Peredo J; Grody WW; Crandall B; Sims M; Cederbaum SD
    Mol Genet Metab; 2010 Dec; 101(4):413-6. PubMed ID: 20817516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of the total number of disease-causing mutations in ornithine transcarbamylase (OTC) deficiency. Value of the OTC structure in predicting a mutation pathogenic potential.
    Arranz JA; Riudor E; Marco-Marín C; Rubio V
    J Inherit Metab Dis; 2007 Apr; 30(2):217-26. PubMed ID: 17334707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early intervention for late-onset ornithine transcarbamylase deficiency.
    Fujisawa D; Mitsubuchi H; Matsumoto S; Iwai M; Nakamura K; Hoshide R; Harada N; Yoshino M; Endo F
    Pediatr Int; 2015; 57(1):e1-3. PubMed ID: 25711267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A promoter variant in the OTC gene associated with late and variable age of onset hyperammonemia.
    Han ST; Anderson KJ; Bjornsson HT; Longo N; Valle D
    J Inherit Metab Dis; 2022 Jul; 45(4):710-718. PubMed ID: 35605046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humanized liver mouse model with transplanted human hepatocytes from patients with ornithine transcarbamylase deficiency.
    Sugahara G; Yamasaki C; Yanagi A; Furukawa S; Ogawa Y; Fukuda A; Enosawa S; Umezawa A; Ishida Y; Tateno C
    J Inherit Metab Dis; 2021 May; 44(3):618-628. PubMed ID: 33336822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New mutation and prenatal diagnosis in ornithine transcarbamylase deficiency.
    Nussbaum RL; Boggs BA; Beaudet AL; Doyle S; Potter JL; O'Brien WE
    Am J Hum Genet; 1986 Feb; 38(2):149-58. PubMed ID: 3004207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The functional impact of 1,570 individual amino acid substitutions in human OTC.
    Lo RS; Cromie GA; Tang M; Teng K; Owens K; Sirr A; Kutz JN; Morizono H; Caldovic L; Ah Mew N; Gropman A; Dudley AM
    Am J Hum Genet; 2023 May; 110(5):863-879. PubMed ID: 37146589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The phenotypic and mutational spectrum of Thai female patients with ornithine transcarbamylase deficiency.
    Chongsrisawat V; Damrongphol P; Ittiwut C; Ittiwut R; Suphapeetiporn K; Shotelersuk V
    Gene; 2018 Dec; 679():377-381. PubMed ID: 30223008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Silico Analysis of a De Novo OTC Variant as a Cause of Ornithine Transcarbamylase Deficiency.
    Ozdemir Y; Cag M; Gul S; Yüksel Z; Ergoren MC
    Appl Immunohistochem Mol Morphol; 2022 Feb; 30(2):153-156. PubMed ID: 34670952
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.